Fractalkine: one chemokine, many functions
- 22 January 2009
- journal article
- Published by American Society of Hematology in Blood
- Vol. 113 (4), 767-768
- https://doi.org/10.1182/blood-2008-11-189860
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Fractalkine Deficiency Markedly Reduces Macrophage Accumulation and Atherosclerotic Lesion Formation in CCR2 −/− MiceCirculation, 2008
- Combined Inhibition of CCL2, CX3CR1, and CCR5 Abrogates Ly6C hi and Ly6C lo Monocytosis and Almost Abolishes Atherosclerosis in Hypercholesterolemic MiceCirculation, 2008
- Major reduction of atherosclerosis in fractalkine (CX3CL1)-deficient mice is at the brachiocephalic artery, not the aortic rootProceedings of the National Academy of Sciences, 2004
- Blood Monocytes Consist of Two Principal Subsets with Distinct Migratory PropertiesImmunity, 2003
- Decreased atherosclerosis in CX3CR1–/– mice reveals a role for fractalkine in atherogenesisJournal of Clinical Investigation, 2003
- Tumor Necrosis Factor-α-converting Enzyme (ADAM17) Mediates the Cleavage and Shedding of Fractalkine (CX3CL1)Journal of Biological Chemistry, 2001
- Identification and Molecular Characterization of Fractalkine Receptor CX3CR1, which Mediates Both Leukocyte Migration and AdhesionCell, 1997
- A new class of membrane-bound chemokine with a CX3C motifNature, 1997